NCDs in the Context of the SDGs - a presentation delivered by Dr Albert Francis Domingo (Consultant, WHO Regional Office for the Western Pacific) at the Philippines' DOH NCRO Operational Planning Workshop for Local Strategic Plans on Noncommunicable Diseases Prevention and Control Programs, 2-4 December 2015. (Adapted from an earlier presentation by Dr Douglass Bettcher, Director, Prevention of NCDs, WHO.)
Safe Motherhood Program in Nepal: Challenges and Way ForwardKusumsheela Bhatta
The safe motherhood programme is one of the priority programme of Nepal. The goal of the National Safe Motherhood Program is to reduce maternal and neonatal morbidity and mortality and to improve the maternal and neonatal health through preventive and promotive activities as well as by addressing avoidable factors that cause death during pregnancy, childbirth and postpartum period. This presentation incorporates historical context, introduction, major achievements, actors, what Went Well, what didn’t go well, limitations, challenges, way forward of Safe Motherhood Program in Nepal.
Safe Motherhood Program in Nepal: Challenges and Way ForwardKusumsheela Bhatta
The safe motherhood programme is one of the priority programme of Nepal. The goal of the National Safe Motherhood Program is to reduce maternal and neonatal morbidity and mortality and to improve the maternal and neonatal health through preventive and promotive activities as well as by addressing avoidable factors that cause death during pregnancy, childbirth and postpartum period. This presentation incorporates historical context, introduction, major achievements, actors, what Went Well, what didn’t go well, limitations, challenges, way forward of Safe Motherhood Program in Nepal.
National Program for Prevention and Control of Cancer, Diabetes, CVD and Stro...Vivek Varat
Government of India initiated a National Programme for Prevention and Control of Cancers, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) during 2010-11 after integrating the National Cancer Control Programme (NCCP) with (NPDCS).
NCDs, also known as chronic diseases, tend to be of long duration and are the result of a combination of genetic, physiological, environmental and behaviours factors.
The main types of NCDs are cardiovascular diseases (like heart attacks and stroke), cancers, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma) and diabetes
The general shift from acute infectious and deficiency diseases characteristic of underdevelopment to chronic non-communicable diseases characteristic of modernization and advanced levels of development is usually referred to as the "epidemiological transition".
Universal health coverage as a concept was born in 1883 when Germany introduced health coverage for achieving health status of its young population.India, is still attempting to find a way for providing appropriate, affordable and accessible health care to its population.
international health regulation
RULES AND GUIDELINES OF INTERNATIONAL HEALTH REGULATIONS:
International health regulations evolution:
The IHR originated with ISR adapted at the international sanitary conference in Paris in 1851
Cholera epidemic 🡪 Europe 🡪1830 & 1847
Need international cooperation
22nd World Health Assembly (1969) adopted, revised and consolidated the international sanitary regulations, renames as IHR in 1969
26th World Health Assembly 1973🡪amendment in IHR
Thirty-fourth World Health Assembly amended the IHR (1969) to exclude smallpox in the list of notifiable diseases.
During the Forty-Eighth World Health Assembly in 1995, WHO and Member States agreed on the need to revise the IHR (1969) most notably:
narrow scope of notifiable diseases (cholera, plague, yellow fever),
The past few decades have seen the emergence and re-emergence of infectious diseases.
The emergence of “new” infectious agents Ebola, Hemorrhagic Fever and the re-emergence of cholera and plague in South America and India, respectively;
dependence on official country notification; and
lack of a formal internationally coordinated mechanism to prevent the international spread of disease.
These challenges were placed against the backdrop of the increased travel and trade characteristic of the 20th century.
The IHR (2005) entered into force, generally, on 15 June 2007, and are currently binding on 194 countries (States Parties) across the globe, including all 193 Member States of WHO.
summary:
The International Health Regulations (IHR) are an international legal instrument that covers measures for preventing the transnational spread of infectious diseases.
IHR is an instrument of international law that is legally binding on countries.
IHR is a set of regulations that is legally binding upon 196 state parties.
This legal binding is adopted by 196 countries, including all (194) WHO member states.
IHR is a benchmark to state the rights and obligations of countries to report public health actions.
The objective of IHR is to work together to protect global health security.
IHR are the international agreements with the objective of preventing the spread of public health threats without unnecessary impairment of international travel and trade.
The IHR was adopted by the 58th World Health Assembly in 2005 through Resolution WHA 58.3.
International Health was in action since 15 June 2007
The International Health Regulations (IHR 2005) are a set of regulations legally binding on 196 States Parties, including all WHO Member States. They contribute to global public health security by providing a new framework for the coordination of the management of events that may constitute a public health emergency of international concern, and improve the capacity of all countries to detect, assess, notify and respond to public health threats.
The IHR were adopted at the Fifty-eighth World Health Assembly on 23 May 2005 and entered into force on 15 June 2007.
National programme for prevention and control of cancer, diabetes, CVDs and s...Dr Lipilekha Patnaik
NCDs are surpassing the burden of communicable diseases in India, need for National Programme on Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke was envisaged.
Presented by Oleg Chestnov, Assistant Director-General for Noncommunicable Diseases and Mental Health, WHO, at the 64th session of the WHO Regional Committee for Europe.
National Program for Prevention and Control of Cancer, Diabetes, CVD and Stro...Vivek Varat
Government of India initiated a National Programme for Prevention and Control of Cancers, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) during 2010-11 after integrating the National Cancer Control Programme (NCCP) with (NPDCS).
NCDs, also known as chronic diseases, tend to be of long duration and are the result of a combination of genetic, physiological, environmental and behaviours factors.
The main types of NCDs are cardiovascular diseases (like heart attacks and stroke), cancers, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma) and diabetes
The general shift from acute infectious and deficiency diseases characteristic of underdevelopment to chronic non-communicable diseases characteristic of modernization and advanced levels of development is usually referred to as the "epidemiological transition".
Universal health coverage as a concept was born in 1883 when Germany introduced health coverage for achieving health status of its young population.India, is still attempting to find a way for providing appropriate, affordable and accessible health care to its population.
international health regulation
RULES AND GUIDELINES OF INTERNATIONAL HEALTH REGULATIONS:
International health regulations evolution:
The IHR originated with ISR adapted at the international sanitary conference in Paris in 1851
Cholera epidemic 🡪 Europe 🡪1830 & 1847
Need international cooperation
22nd World Health Assembly (1969) adopted, revised and consolidated the international sanitary regulations, renames as IHR in 1969
26th World Health Assembly 1973🡪amendment in IHR
Thirty-fourth World Health Assembly amended the IHR (1969) to exclude smallpox in the list of notifiable diseases.
During the Forty-Eighth World Health Assembly in 1995, WHO and Member States agreed on the need to revise the IHR (1969) most notably:
narrow scope of notifiable diseases (cholera, plague, yellow fever),
The past few decades have seen the emergence and re-emergence of infectious diseases.
The emergence of “new” infectious agents Ebola, Hemorrhagic Fever and the re-emergence of cholera and plague in South America and India, respectively;
dependence on official country notification; and
lack of a formal internationally coordinated mechanism to prevent the international spread of disease.
These challenges were placed against the backdrop of the increased travel and trade characteristic of the 20th century.
The IHR (2005) entered into force, generally, on 15 June 2007, and are currently binding on 194 countries (States Parties) across the globe, including all 193 Member States of WHO.
summary:
The International Health Regulations (IHR) are an international legal instrument that covers measures for preventing the transnational spread of infectious diseases.
IHR is an instrument of international law that is legally binding on countries.
IHR is a set of regulations that is legally binding upon 196 state parties.
This legal binding is adopted by 196 countries, including all (194) WHO member states.
IHR is a benchmark to state the rights and obligations of countries to report public health actions.
The objective of IHR is to work together to protect global health security.
IHR are the international agreements with the objective of preventing the spread of public health threats without unnecessary impairment of international travel and trade.
The IHR was adopted by the 58th World Health Assembly in 2005 through Resolution WHA 58.3.
International Health was in action since 15 June 2007
The International Health Regulations (IHR 2005) are a set of regulations legally binding on 196 States Parties, including all WHO Member States. They contribute to global public health security by providing a new framework for the coordination of the management of events that may constitute a public health emergency of international concern, and improve the capacity of all countries to detect, assess, notify and respond to public health threats.
The IHR were adopted at the Fifty-eighth World Health Assembly on 23 May 2005 and entered into force on 15 June 2007.
National programme for prevention and control of cancer, diabetes, CVDs and s...Dr Lipilekha Patnaik
NCDs are surpassing the burden of communicable diseases in India, need for National Programme on Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke was envisaged.
Presented by Oleg Chestnov, Assistant Director-General for Noncommunicable Diseases and Mental Health, WHO, at the 64th session of the WHO Regional Committee for Europe.
Non-Communicable Diseases: Malaysia in Global Public HealthFeisul Mustapha
Paper presented at a CME Session, held in conjunction with the NIH Research Week 2014, 26 November 2014 at the Institute for Health Management, Bangsar
Scope: The action plan provides a road map and a menu of policy options for all Member States and other stakeholders, to take coordinated and coherent action, at all levels, local to global, to attain the nine voluntary global targets, including that of a 25% relative reduction in premature mortality from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases by 2025.
Focus: The main focus of this action plan is on four types of NCDs — cardiovascular diseases, cancer, chronic respiratory diseases and diabetes — which make the largest contribution to morbidity and mortality due to NCDs, and on four shared behavioral risk factors — tobacco use, unhealthy diet, physical inactivity and harmful use of alcohol. It recognizes that the conditions in which people live and work and their lifestyles influence their health and quality of life.
This is the last keynote address I made at the International Medical Informatics Conference (MEDINFO).The speech presented the areas in which eHealth can contributed to health and well-being, the emerging trend of using big data in health and examples of how big data from mobile phones, social media and internet have been used.
Resolutions and decisions of regional interest adopted by the Seventy-second World Health Assembly and the Executive Board at its 144th and 145th sessions
Universal Health Care: The Philippine journey towards accessing quality healt...Albert Domingo
Presentation delivered by WHO Consultant for Health Systems Strengthening Dr Albert Domingo at the University of Santo Tomas, on the occasion of UHC Day 2018.
Research and Understanding for Universal Health Care - #RU4UHCAlbert Domingo
Research priorities in support of universal health care (UHC) implementation in the Philippines. Delivered in plenary at the 3rd Western Visayas Health Research Conference, 6 Nov 2018, Iloilo City, Philippines.
NCD Prevention and Control as a Health System Strengthening InterventionAlbert Domingo
Lecture on NCD Prevention and Control as a Health System Strengthening Intervention delivered by Dr Albert Francis Domingo at the UP Manila College of Public Health on 19 January 2018.
Universal Health Coverage Action Framework for the Western Pacific RegionAlbert Domingo
Presentation by Dr Albert Francis Domingo, delivered at the meeting on rehabilitation as part of the continuum of people-centred health care, Seoul (Republic of Korea), 13-15 December 2016.
Addressing hearing loss through a health care systems approachAlbert Domingo
Presentation by Dr Albert Francis Domingo, Consultant of the Division of NCDs and Health through the Life-Course, WHO Regional Office for the Western Pacific delivered at the Multi-country Workshop on Ear and Hearing Care in the Western Pacific Region (6-7 Dec 2016, Beijing, China).
Insights and Opportunities for the Philippine Medical Student in the ASEAN Co...Albert Domingo
Presentation delivered by Albert Francis E. Domingo, MD, MSc at San Beda College Mendiola, during the 49th Annual National Convention of the Association of the Philippine Medical Colleges. Discusses ASEAN integration and the trade in health services, from the perspective of future physicians (i.e. medical students).
Dissecting the Reproductive Health Law Policy ProcessAlbert Domingo
Slides intended for interactive discussion on the policy process behind the Philippines' Reproductive Health law (RA 10354), following the framework of Walt and Gilson (1994)'s health policy triangle and the legislative threshold of Gray (2004).
Western Pacific Updates on Noncommunicable DiseasesAlbert Domingo
Western Pacific Updates on Noncommunicable Diseases - a presentation delivered by Dr Albert Francis Domingo (Consultant, WHO Regional Office for the Western Pacific) at the Philippines' DOH NCRO Operational Planning Workshop for Local Strategic Plans on Noncommunicable Diseases Prevention and Control Programs, 2-4 December 2015. (Adapted from an earlier presentation by Dr Susan Mercado, Director, DNH/WPRO.)
Introduction to Technical Writing: The Policy BriefAlbert Domingo
A short presentation on the basics of writing a policy brief for use in the health sector. This is meant to be accompanied by hands-on learning materials (pre-test, exercise, post-test).
Noncommunicable Diseases as the Focus for a Diagonal Approach to Strengthenin...Albert Domingo
This is an overview of the work-based placement I had at the World Health Organization Regional Office for the Western Pacific, in Manila, the Philippines. My research topic has been about noncommunicable diseases or NCDs as the focus for a diagonal approach to strengthening health systems.
The state in global health (focus on LICs/MICs)Albert Domingo
A report/presentation on the changing dynamics of the power of the state viz. external actors in formulating health policy, particularly in low income countries and middle income countries.
Medical Governance, Health Policy, and Health Sector Reform in the PhilippinesAlbert Domingo
Suggested citation:
Domingo, Albert Francis E. "Medical Governance, Health Policy, and Health Sector Reform in the Philippines.” De La Salle Health Sciences Institute (DLSHSI). DLSHSI College of Medicine, Dasmarinas, Cavite. 27 Jun. 2014. Lecture.
Understanding the Supreme Court Decision on the RH LawAlbert Domingo
Briefing on the Decision of the Supreme Court of the Philippines in the consolidated case of Imbong v. Ochoa (G.R. Nos. 204819, 204934, 204957, 204988, 205003, 205043, 205138, 205478, 205491, 205720, 206355, 207111, 207172 & 207563, April 8, 2014) assailing the constitutionality of RA 10354
(Updated draft as of 19 May 2014. Note: The analyses of this presentation may still change until the Decision becomes final and executory.)
Slide presentation used at one of the breakout/parallel sessions of the 4th National Medical Students' Conference (NMSC). On health policy in the Philippines and the country's Kalusugan Pangkalahatan (Universal Health Care) program.
Policy Implications of Healthcare Associated InfectionsAlbert Domingo
On February 19, 2014 at the Ateneo School of Medicine and Public Health in Pasig City, Dr. Albert Domingo presented an introduction to the economic impact of healthcare associated infections (HAIs) as well as related concepts in health policy and management. The speaker discussed common approaches taken to ascertain the economic impact of HAIs, followed by factors/considerations in Philippine health policy and management that must be understood and adjusted in order to minimize HAIs.
Medical Governance and Health Policy in the PhilippinesAlbert Domingo
An overview of key concepts and present trends in medical governance, health policy, and health sector reform in the Philippines, presented by Dr. Albert Domingo at the De La Salle Health Sciences Institute - College of Medicine on Sep. 26, 2013 for the subject "Perspectives in Medicine".
Includes the broad concept of medical governance as applied to various settings, from the point of care between provider and client/patient, to national and global health systems. Also touches on the practice of evidence-based healthcare as applied to the scale-up of innovations necessary to accelerate reform implementation, with grounding in the operational realities of implementation arrangements faced by sector managers on a day-to-day basis.
Suggested Citation:
Domingo, Albert Francis E. "Medical Governance, Health Policy, and Health Sector Reform in the Philippines: An Overview of Key Concepts and Present Trends." De La Salle Health Sciences Institute (DLSHSI). DLSHSI College of Medicine, Dasmarinas, Cavite. 26 Sep. 2013. Lecture.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
1. NCDs in the Context of the SDGs1 |
NCDs in the context of the SDGs
2030 Agenda for Sustainable Development
Albert Francis E. Domingo MD MSc
Noncommunicable Diseases and Health Promotion
Division of NCD and Health through the Life-Course
WHO Regional Office for the Western Pacific
3 December 2015
2. NCDs in the Context of the SDGs2 |
From the Millennium Development Goals in 2000
3. NCDs in the Context of the SDGs3 |
From: http://data.worldbank.org/news/significant-progress-towards-achieving-MDGs
From the Millennium Development Goals in 2000
4. NCDs in the Context of the SDGs4 |
2011
Political
Declaration
2014
Outcome
Document
2011
Moscow
Declaration
2015
SDGs
2015
AAAA
2018
3rd HLM
Historic crossroads: NCD getting to 2018
2018
5. NCDs in the Context of the SDGs5 |
Historic crossroads: NCDs included in the 2030 Agenda for Sustainable Development
6. NCDs in the Context of the SDGs6 |
SDG3: Ensure healthy lives and
promote well-being for all at all ages
• Reduce maternal mortality
• End preventable deaths of newborns and
children under 5 years of age
• End epidemics of AIDS, TB, malaria and
NTDs and combat hepatitis, water-borne
diseases and other communicable
diseases
• Reduce by one third premature
mortality from NCDs and promote
mental health
• Strengthen prevention and
treatment of substance abuse
• Halve deaths and injuries from road traffic
accidents; ensure universal access to
sexual and reproductive health
• Achieve universal health coverage,
access to quality essential health-
care services and access to
medicines and vaccines
• Substantially reduce deaths and illnesses
from hazardous chemicals, pollutants and
contaminants
• Strengthen implementation of the
WHO FCTC, as appropriate
• Support R&D of vaccines and
medicines in accordance with the
Doha Declaration on the TRIPS
Agreement and Public Health
• Substantially increase health financing and
development of the health workforce in
developing countries
• Strengthen country capacities for early
warning, risk reduction and management
of national and global health risks
7. NCDs in the Context of the SDGs7 |
Commits governments to develop national
responses:
Target 3.4: By 2030, reduce by one third
premature mortality from NCDs
Target 3.5: Strengthen responses to reduce
the harmful use of alcohol
Target 3.8: Achieve universal health
coverage
Target 3.a: Strengthen the implementation
of the WHO Framework Convention on
Tobacco Control
Target 3.b: Support research and
development of vaccines and medicines for
NCDs that primarily affect developing
countries
Target 3.b: Provide access to affordable
essential medicines and vaccines for NCDs
2030 Agenda for Sustainable Development
8. NCDs in the Context of the SDGs8 |
Global cost of implementing the SDGs between 2016 and 2030
US$175 trillion
Domestic public
resources
Private business
and finance
International
public finance
International
trade as an
engine for
development
Debt
sustainability
Systemic issues
(UN leadership
role)
Science,
technology,
innovation and
capacity building
Data
9. NCDs in the Context of the SDGs9 |
Tobacco tax as a revenue stream for financing for development
The Addis Ababa Action Agenda
recognizes that price and tax measures
on tobacco represent a revenue stream
for financing for development in many
countries
Governments already collect nearly
US$270 billion in tobacco excise
revenues each year
Tobacco taxation offers a win-win
policy option for governments
Increased tobacco taxes can bring in
important revenue to finance the
SDGs
WHO FCTC implementation is a target
of the SDGs
10. NCDs in the Context of the SDGs10 |
Tobacco tax as a revenue stream for financing for development
11. NCDs in the Context of the SDGs11 |
2025 milestone: 9 voluntary global NCD targets
By 2030, reduce by one third premature mortality from NCDs
2030 milestone: NCD-related targets in the SDGs
2018 milestone: Four time-bound commitments
WHO Global
NCD Action
Plan 2013-
2020
2011 UN
Political
Declaration on
NCDs
2014 UN
Outcome
Document on
NCDs
Governance Risk factors Health systems Surveillance
Components of national NCD responses
WHO Regional
NCD Action
Plans
Getting to 2030: Global vision
Sustainable
Development
Goals
12. NCDs in the Context of the SDGs12 |
Four time-bound commitments in the 2014 UN Outcome Document on NCDs
By 2015:
Set national NCD targets for 2025 or 2030 and monitor results
By 2015:
Develop a national multisectoral
action plan
By 2016:
Implement the "best buy" interventions
to reduce NCD risk factors
By 2016:
Implement the "best buy" interventions to strengthen health
systems to address NCDs
13. NCDs in the Context of the SDGs13 |
Based on the set of 10 progress
monitoring indicators published
by WHO in May 2015
Indicators show progress
achieved by countries in
implementing the four time-
bound commitments for 2015
and 2016
Data drawn from several
sources generated by WHO and
validated with supporting
documentation provided by
countries
WHO NCD Progress Monitor 2015 published on 25 September 2015
14. NCDs in the Context of the SDGs14 |
10 Progress Monitoring Indicators
15. NCDs in the Context of the SDGs15 |
10 Progress Monitoring Indicators
16. NCDs in the Context of the SDGs16 |
WHO NCD Progress Monitor 2015: Philippines
17. NCDs in the Context of the SDGs17 |
WHO NCD Progress Monitor 2015: Progress is insufficient
0 5 10 15 20 25 30 35
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Number of Member States
Numberof"fullyachieved"Indicators
18. NCDs in the Context of the SDGs18 |
Including subnational
demonstration
Bolder measures are needed by
governments, international partners and WHO
to ensure that the four time-bound commitments for
2015 and 2016 included in the 2014 UN Outcome
Document on NCDs are fully implemented
WHO NCD Progress Monitor 2015: Progress is insufficient
19. NCDs in the Context of the SDGs19 |
What WHO is doing to support countries to get ready for 2018?
Governance Risk factors Health systems Surveillance
UN Agencies
(coordinated through
the UN Task Force on
NCDs)
WHO
Secretariat
(through Programme
Budget
2016-2017)
Member
States and
non-State
actors
(coordinated through
the WHO GCM/NCD)
Development and implementation of national NCD responses
• Normative work
• Technical assistance
• Technical assistance
(beyond the health sector)
• Advocacy
• Network
• Forum
Components of national NCD responses
20. NCDs in the Context of the SDGs20 |
Time to scale up action
Third High-level Meeting on NCDs
2018
21. NCDs in the Context of the SDGs21 |
Thank you
NCD@wpro.who.int
03/12/2015 21
Editor's Notes
Original presentation by Dr Douglas Bettcher, Director, Prevention of NCDs, WHO (27 Nov 2015)
With modifications and annotations (during delivery) by Dr Albert Francis E Domingo, Consultant, Noncommunicable Diseases and Health Promotion, DNH, WPRO (2 Dec 2015)
AAAA = Addis Ababa Action Agenda: price and tax measures on tobacco represent a revenue stream for financing for development in many countries
We are three years away from third high level meeting in 2018, so now is the time to for member states to deliver on the four time-bound commitments in the outcome document of 2014.